Sun Cadila Dr Reddys

Mar-16 E Pharma Lupin Cipla Health Labs Glenmark

1 0 1 -1.422E-14 0 4.4019E-14 0
Min Z 1

Sun Cadila Dr Reddys

Input Resources Pharma Lupin Cipla Health Labs Glenmark
Long Term Borrowings -13.86 1,929.27 13.86 0.13 430 994.4 0
Short Term Borrowings -372.96 3,733.72 372.96 1,131.68 604.3 2,089.60 787.42
Trade Payables -1,128.94 1,772.44 1,128.94 990.84 899.9 719.2 1,625.95
Finance Costs -24.11 530.64 24.11 147.07 26.5 63.8 36.22
Other Expenses -2,743.15 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40 1,644.97

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80 5,906.97
Other Income 431.82 186.85 280.3 174.9 244.8 117.28
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50 3,057.66
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50 1,484.27
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80 1,321.92
Weight 1 1 1 1 1 1
 Aurobindo Alkem Jubiliant
Alembic Pharma Ipca Lab Life
0 0 0 0 0
1

Aurobindo Alkem Jubiliant

Alembic Pharma Ipca Lab Life Lupin
0 334.76 484.28 0 1,123.36 7.751946E-14 <= 0
0 3,417.15 182.86 350.62 433.17 -1.09987E-09 <= 0
500.21 1,278.67 415.24 466.5 364.49 -3.54152E-09 <= 0
2.37 229.31 28.6 58.67 202.43 -7.52904E-11 <= 0
803.99 1,616.82 880.1 1,057.34 644.05 -8.54469E-09 <= 0

2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 10882.87 >= 10,882.87

5.51 188.36 27.67 251.28 61.74 186.85 >= 186.85
371.5 4,380.97 441.45 480.44 320.52 4545.15 >= 4,545.15
698.14 1,626.70 880.1 700.19 79.07 2830.87 >= 2,830.87
697.25 2,568.13 1,927.88 847.07 1,408.18 2327.84 >= 2,327.84
1 1 1 1 1 1= 1
 Sun Cadila Dr Reddys
Mar-20 E Pharma Lupin Cipla Health Labs Glenmark
1 0 0 1 0 0 0
Min Z 1

Sun Cadila Dr Reddys

Input Resources Pharma Lupin Cipla Health Labs Glenmark
Long Term Borrowings -0.13 1,929.27 13.86 0.13 430 994.4 0
Short Term Borrowings -1,131.68 3,733.72 372.96 1,131.68 604.3 2,089.60 787.42
Trade Payables -990.84 1,772.44 1,128.94 990.84 899.9 719.2 1,625.95
Finance Costs -147.07 530.64 24.11 147.07 26.5 63.8 36.22
Other Expenses -3,386.48 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40 1,644.97

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80 5,906.97
Other Income 431.82 186.85 280.3 174.9 244.8 117.28
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50 3,057.66
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50 1,484.27
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80 1,321.92
Weight 1 1 1 1 1 1
Wockhar Aurobind Strides Jubiliant
dt o Pharma Pharma Alkem Lab Life
0 0 -1.347736E-16 2.220446E-16 0
1

Aurobind Jubiliant
Alembic o Pharma Ipca Alkem Lab Life Cipla
0 334.76 484.28 0 1,123.36 -6.526817E-14 <= 0
0 3,417.15 182.86 350.62 433.17 5.3208574E-14 <= 0
500.21 1,278.67 415.24 466.5 364.49 4.7620408E-14 <= 0
2.37 229.31 28.6 58.67 202.43 9.1728313E-15 <= 0
803.99 1,616.82 880.1 1,057.34 644.05 1.1616237E-13 <= 0

2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 11873.46 >= 11,873.46

5.51 188.36 27.67 251.28 61.74 280.3 >= 280.3
371.5 4,380.97 441.45 480.44 320.52 1896.41 >= 1,896.41
698.14 1,626.70 880.1 700.19 79.07 1462.3 >= 1,462.30
697.25 2,568.13 1,927.88 847.07 1,408.18 3702.28 >= 3,702.28
1 1 1 1 1 1= 1
 Cadila Dr Reddys
E Sun Pharma Lupin Cipla Health Labs
1.5161455511 0 0.4137208 0.1768951427 0 0
Min Z 0

Cadila Dr Reddys
Input Resources Sun Pharma Lupin Cipla Health Labs
Long Term Borrowings -430 1,929.27 13.86 0.13 430 994.4
Short Term Borrowings -1443.4 3,733.72 372.96 1,131.68 604.3 2,089.60
Trade Payables -862.7 1,772.44 1,128.94 990.84 899.9 719.2
Finance Costs -233.9 530.64 24.11 147.07 26.5 63.8
Other Expenses -1895.2 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80
Other Income 431.82 186.85 280.3 174.9 244.8
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80
Weight 1 1 1 1 1
 Wockhar Aurobindo Strides Alkem Jubiliant
Glenmark dt Pharma Pharma Lab Life
0.409384 0 0 0 0 0
0

Aurobindo Alkem Jubiliant Cadila

Glenmark Alembic Pharma Ipca Lab Life Health
0 0 334.76 484.28 0 1,123.36 -646.18542078 <= 0
787.42 0 3,417.15 182.86 350.62 433.17 -1511.5572762 <= 0
1,625.95 500.21 1,278.67 415.24 466.5 364.49 8.9266905E-10 <= 0
36.22 2.37 229.31 28.6 58.67 202.43 -303.80777634 <= 0
1,644.97 803.99 1,616.82 880.1 1,057.34 644.05 -466.02451545 <= 0

5,906.97 2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 9021.0462699 >= 6,529.60

117.28 5.51 188.36 27.67 251.28 61.74 174.9 >= 174.9
3,057.66 371.5 4,380.97 441.45 480.44 320.52 3467.6460208 >= 1,707.30
1,484.27 698.14 1,626.70 880.1 700.19 79.07 2037.5 >= 2,037.50
1,321.92 697.25 2,568.13 1,927.88 847.07 1,408.18 2159.1641169 >= 1,998.60
1 1 1 1 1 1 1= 1
 Sun Cadila Dr Reddys
Mar-20 E Pharma Lupin Cipla Health Labs Glenmark
1 0 0 1.6995E-11 0 1 0
Min Z 1

Sun Cadila Dr Reddys

Input Resources Pharma Lupin Cipla Health Labs Glenmark
Long Term Borrowings -994.40 1,929.27 13.86 0.13 430 994.4 0
Short Term Borrowings -2,089.60 3,733.72 372.96 1,131.68 604.3 2,089.60 787.42
Trade Payables -719.20 1,772.44 1,128.94 990.84 899.9 719.2 1,625.95
Finance Costs -63.80 530.64 24.11 147.07 26.5 63.8 36.22
Other Expenses -3,429.40 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40 1,644.97

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80 5,906.97
Other Income 431.82 186.85 280.3 174.9 244.8 117.28
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50 3,057.66
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50 1,484.27
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80 1,321.92
Weight 1 1 1 1 1 1
Wockhar Aurobind Strides Alkem Jubiliant
dt o Pharma Pharma Lab Life
0 0 0 6.816E-13 0
1

Aurobind Alkem Jubiliant

Alembic o Pharma Ipca Lab Life Dr Reddys Labs
0 334.76 484.28 0 1,123.36 -3.65E-08 <= 0
0 3,417.15 182.86 350.62 433.17 -5.72E-08 <= 0
500.21 1,278.67 415.24 466.5 364.49 -9.24E-09 <= 0
2.37 229.31 28.6 58.67 202.43 1.982E-10 <= 0
803.99 1,616.82 880.1 1,057.34 644.05 -6.76E-08 <= 0

2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 10234.8 >= 10,234.80

5.51 188.36 27.67 251.28 61.74 244.8 >= 244.8
371.5 4,380.97 441.45 480.44 320.52 3893.5 >= 3,893.50
698.14 1,626.70 880.1 700.19 79.07 1354.5 >= 1,354.50
697.25 2,568.13 1,927.88 847.07 1,408.18 3593.8 >= 3,593.80
1 1 1 1 1 1= 1
 Sun Cadila Dr Reddys
Mar-20 E Pharma Lupin Cipla Health Labs
2.0446882 0.1467028 0 0.1756654 0 0.6460124
Min Z 1

Sun Cadila Dr Reddys

Input Resources Pharma Lupin Cipla Health Labs
Long Term Borrowings 0 1,929.27 13.86 0.13 430 994.4
Short Term Borrowings -787.42 3,733.72 372.96 1,131.68 604.3 2,089.60
Trade Payables -1625.95 1,772.44 1,128.94 990.84 899.9 719.2
Finance Costs -36.22 530.64 24.11 147.07 26.5 63.8
Other Expenses -1644.97 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80
Other Income 431.82 186.85 280.3 174.9 244.8
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80
Weight 1 1 1 1 1
 Aurobindo Strides Jubiliant
Glenmark Wockhardt Pharma Pharma Alkem Lab Life
0 0 0.0172129 0.0144065 0 0
0

Aurobindo Jubiliant
Glenmark Alembic Pharma Ipca Alkem Lab Life Glenmark
0 0 334.76 484.28 0 1,123.36 938.18579 <= 0
787.42 0 3,417.15 182.86 350.62 433.17 547.87666 <= 0
1,625.95 500.21 1,278.67 415.24 466.5 364.49 -2397.8787 <= 0
36.22 2.37 229.31 28.6 58.67 202.43 75.197565 <= 0
1,644.97 803.99 1,616.82 880.1 1,057.34 644.05 -6.8523405 <= 0

5,906.97 2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 9959.6552 >= 5906.97

117.28 5.51 188.36 27.67 251.28 61.74 274.37289 >= 117.28
3,057.66 371.5 4,380.97 441.45 480.44 320.52 3226.0235 >= 3057.66
1,484.27 698.14 1,626.70 880.1 700.19 79.07 1015.1139 >= 1484.27
1,321.92 697.25 2,568.13 1,927.88 847.07 1,408.18 3559.3331 >= 1321.92
1 1 1 1 1 1 1= 1
 Sun Cadila Dr Reddys
Mar-20 E Pharma Lupin Cipla Health Labs Glenmark
1 0 0 0 0 0 0
Min Z 1

Sun Cadila Dr Reddys

Input Resources Pharma Lupin Cipla Health Labs Glenmark
Long Term Borrowings 0 1,929.27 13.86 0.13 430 994.4 0
Short Term Borrowings 0 3,733.72 372.96 1,131.68 604.3 2,089.60 787.42
Trade Payables -500.21 1,772.44 1,128.94 990.84 899.9 719.2 1,625.95
Finance Costs -2.37 530.64 24.11 147.07 26.5 63.8 36.22
Other Expenses -803.99 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40 1,644.97

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80 5,906.97
Other Income 431.82 186.85 280.3 174.9 244.8 117.28
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50 3,057.66
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50 1,484.27
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80 1,321.92
Weight 1 1 1 1 1 1
 Aurobind Strides Alkem
Alembic o Pharma Pharma Lab Jubiliant Life
1 0 0 0 0
0

Aurobind Alkem
Alembic o Pharma Ipca Lab Jubiliant Life Alembic
0 334.76 484.28 0 1,123.36 0 <= 0
0 3,417.15 182.86 350.62 433.17 0 <= 0
500.21 1,278.67 415.24 466.5 364.49 0 <= 0
2.37 229.31 28.6 58.67 202.43 0 <= 0
803.99 1,616.82 880.1 1,057.34 644.05 0 <= 0

2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 2940.87 >= 2,940.87

5.51 188.36 27.67 251.28 61.74 5.51 >= 5.51
371.5 4,380.97 441.45 480.44 320.52 371.5 >= 371.50
698.14 1,626.70 880.1 700.19 79.07 698.14 >= 698.14
697.25 2,568.13 1,927.88 847.07 1,408.18 697.25 >= 697.25
1 1 1 1 1 1= 1
 Cadila Dr Reddys
Mar-20 E Sun Pharma Lupin Cipla Health Labs
1 7.396967E-14 2.654521E-12 0 0 0
Min Z 1

Cadila Dr Reddys
Input Resources Sun Pharma Lupin Cipla Health Labs
Long Term Borrowings -334.76 1,929.27 13.86 0.13 430 994.4
Short Term Borrowings -3417.15 3,733.72 372.96 1,131.68 604.3 2,089.60
Trade Payables -1278.67 1,772.44 1,128.94 990.84 899.9 719.2
Finance Costs -229.31 530.64 24.11 147.07 26.5 63.8
Other Expenses -1616.82 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80
Other Income 431.82 186.85 280.3 174.9 244.8
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80
Weight 1 1 1 1 1
 Aurobind Alkem Jubiliant
Glenmark Alembic o Pharma IPCA Lab Life
0 0 1 0 0 0
1

Aurobind Alkem Jubiliant

Glenmark Alembic o Pharma Ipca Lab Life Aurobindo Pharma
0 0 334.76 484.28 0 1,123.36 -1.766182E-09 <= 0
787.42 0 3,417.15 182.86 350.62 433.17 -1.859507E-08 <= 0
1,625.95 500.21 1,278.67 415.24 466.5 364.49 -4.303956E-09 <= 0
36.22 2.37 229.31 28.6 58.67 202.43 -1.229552E-09 <= 0
1,644.97 803.99 1,616.82 880.1 1,057.34 644.05 -1.860599E-09 <= 0

5,906.97 2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 9078.96 >= 9078.96

117.28 5.51 188.36 27.67 251.28 61.74 188.36 >= 188.36
3,057.66 371.5 4,380.97 441.45 480.44 320.52 4380.97 >= 4380.97
1,484.27 698.14 1,626.70 880.1 700.19 79.07 1626.7 >= 1626.7
1,321.92 697.25 2,568.13 1,927.88 847.07 1,408.18 2568.13 >= 2568.13
1 1 1 1 1 1 1= 1
 Sun Dr Reddys
Mar-20 E Pharma Lupin Cipla Cadila Health Labs
1 0 1.239155E-13 0 1.128649E-13 0
Min Z 1

Sun Dr Reddys
Input Resources Pharma Lupin Cipla Cadila Health Labs
Long Term Borrowings -484.28 1,929.27 13.86 0.13 430 994.4
Short Term Borrowings -182.86 3,733.72 372.96 1,131.68 604.3 2,089.60
Trade Payables -415.24 1,772.44 1,128.94 990.84 899.9 719.2
Finance Costs -28.6 530.64 24.11 147.07 26.5 63.8
Other Expenses -880.1 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80
Other Income 431.82 186.85 280.3 174.9 244.8
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80
Weight 1 1 1 1 1
 Wockhar Aurobind Alkem Jubiliant
Glenmark dt o Pharma Ipca Lab Life
0 0 0 1 0 0
1

Aurobind Alkem Jubiliant

Glenmark Alembic o Pharma Ipca Lab Life Ipca
0 0 334.76 484.28 0 1,123.36 -2.523279E-10 <= 0
787.42 0 3,417.15 182.86 350.62 433.17 1.7053026E-13 <= 0
1,625.95 500.21 1,278.67 415.24 466.5 364.49 -1.796252E-11 <= 0
36.22 2.37 229.31 28.6 58.67 202.43 -1.188738E-11 <= 0
1,644.97 803.99 1,616.82 880.1 1,057.34 644.05 9.094947E-13 <= 0

5,906.97 2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 2803.79 >= 2,803.79

117.28 5.51 188.36 27.67 251.28 61.74 27.67 >= 27.67
3,057.66 371.5 4,380.97 441.45 480.44 320.52 441.45 >= 441.45
1,484.27 698.14 1,626.70 880.1 700.19 79.07 880.1 >= 880.10
1,321.92 697.25 2,568.13 1,927.88 847.07 1,408.18 1927.88 >= 1,927.88
1 1 1 1 1 1 1= 1
 Sun Cadila Dr Reddys
Mar-20 E Pharma Lupin Cipla Health Labs Glenmark
1 0 0 0 0 0 0
Min Z 1

Sun Cadila Dr Reddys

Input Resources Pharma Lupin Cipla Health Labs Glenmark
Long Term Borrowings 0 1,929.27 13.86 0.13 430 994.4 0
Short Term Borrowings -350.62 3,733.72 372.96 1,131.68 604.3 2,089.60 787.42
Trade Payables -466.5 1,772.44 1,128.94 990.84 899.9 719.2 1,625.95
Finance Costs -58.67 530.64 24.11 147.07 26.5 63.8 36.22
Other Expenses -1057.34 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40 1,644.97

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80 5,906.97
Other Income 431.82 186.85 280.3 174.9 244.8 117.28
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50 3,057.66
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50 1,484.27
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80 1,321.92
Weight 1 1 1 1 1 1
Wockhar Aurobind Strides Alkem Jubiliant
dt o Pharma Pharma Lab Life
0 0 0 1 0
1

Aurobind Alkem Jubiliant

Alembic o Pharma Ipca Lab Life Alkem Labs
0 334.76 484.28 0 1,123.36 0 <= 0
0 3,417.15 182.86 350.62 433.17 1.705303E-13 <= 0
500.21 1,278.67 415.24 466.5 364.49 2.273737E-13 <= 0
2.37 229.31 28.6 58.67 202.43 2.842171E-14 <= 0
803.99 1,616.82 880.1 1,057.34 644.05 4.547474E-13 <= 0

2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 3897.1 >= 3897.1

5.51 188.36 27.67 251.28 61.74 251.28 >= 251.28
371.5 4,380.97 441.45 480.44 320.52 480.44 >= 480.44
698.14 1,626.70 880.1 700.19 79.07 700.19 >= 700.19
697.25 2,568.13 1,927.88 847.07 1,408.18 847.07 >= 847.07
1 1 1 1 1 1= 1
 Sun Dr Reddys
Mar-20 E Pharma Lupin Cipla Cadila Health Labs
1 0 0 0 0 0
Min Z 1

Sun Dr Reddys
Input Resources Pharma Lupin Cipla Cadila Health Labs
Long Term Borrowings -1123.36 1,929.27 13.86 0.13 430 994.4
Short Term Borrowings -433.17 3,733.72 372.96 1,131.68 604.3 2,089.60
Trade Payables -364.49 1,772.44 1,128.94 990.84 899.9 719.2
Finance Costs -202.43 530.64 24.11 147.07 26.5 63.8
Other Expenses -644.05 3,447.56 2,743.15 3,386.48 1,867.80 3,429.40

Output Resources
Revenue from Operations 7,262.46 10,882.87 11,873.46 6,529.60 10,234.80
Other Income 431.82 186.85 280.3 174.9 244.8
Trade Receivable 2,016.81 4,545.15 1,896.41 1,707.30 3,893.50
Net profit for the year -1,073.36 2,830.87 1,462.30 2,037.50 1,354.50
Tangible assets 3,512.90 2,327.84 3,702.28 1,998.60 3,593.80
Weight 1 1 1 1 1
 Aurobind Strides Alkem Jubiliant
Glenmark Wockhardt o Pharma Pharma Lab Life
0 0 7.199E-14 0 0 1
1

Aurobind Alkem Jubiliant Jubilant

Glenmark Alembic o Pharma Ipca Lab Life life
0 0 334.76 484.28 0 1,123.36 -1.092258E-08 <= 0
787.42 0 3,417.15 182.86 350.62 433.17 -3.97506E-09 <= 0
1,625.95 500.21 1,278.67 415.24 466.5 364.49 -3.459775E-09 <= 0
36.22 2.37 229.31 28.6 58.67 202.43 -1.956067E-09 <= 0
1,644.97 803.99 1,616.82 880.1 1,057.34 644.05 -6.159553E-09 <= 0

5,906.97 2,940.87 9,078.96 2,803.79 3,897.10 2,742.32 2742.32 >= 2742.32

117.28 5.51 188.36 27.67 251.28 61.74 61.74 >= 61.74
3,057.66 371.5 4,380.97 441.45 480.44 320.52 320.52 >= 320.52
1,484.27 698.14 1,626.70 880.1 700.19 79.07 79.07 >= 79.07
1,321.92 697.25 2,568.13 1,927.88 847.07 1,408.18 1408.18 >= 1408.18
1 1 1 1 1 1 1= 1